{
  "pmcid": "9191810",
  "sha256": "ddf1af922039be444dc5fbc577015cc6481fe70e4c0be78368f532ec18bd59d0",
  "timestamp_utc": "2025-11-10T00:11:44.755771+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 10.130030311017396,
    "reading_ease": 39.67398062730632,
    "word_count": 271
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Title: Randomised Controlled Trial on Labor Epidural Conversion Failure for Caesarean Delivery"
      },
      "Trial_Design": {
        "score": 0,
        "evidence": "The study did not employ randomisation or blinding, as it was a retrospective analysis."
      },
      "Participants": {
        "score": 2,
        "evidence": "including pregnant patients from November 2009 to September 2014 who required CD with a pre-existing labor epidural."
      },
      "Intervention": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Objective": {
        "score": 1,
        "evidence": "This study aimed to evaluate the incidence and risk factors of labor epidural conversion failure requiring general anesthesia for Caesarean delivery (CD)."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was the rate of epidural conversion failure, defined as the need for general anesthesia prior to or during CD."
      },
      "Randomisation_Allocation": {
        "score": 0,
        "evidence": "The study did not employ randomisation or blinding, as it was a retrospective analysis."
      },
      "Blinding": {
        "score": 0,
        "evidence": "The study did not employ randomisation or blinding, as it was a retrospective analysis."
      },
      "Number_Randomised": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Number_Analysed": {
        "score": 1,
        "evidence": "A total of 673 patients were included"
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "Significant risk factors included younger maternal age (OR 0.94, 95% CI 0.90 to 0.97, P = 0.0002), and the use of intravenous fentanyl (OR 0.19, 95% CI 0.10 to 0.35, P < 0.0001) or midazolam (OR 0.26, 95% CI 0.12 to 0.57, P = 0.0008) during CD."
      },
      "Harms": {
        "score": 1,
        "evidence": "No adverse events were reported."
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "The study was not registered as a trial"
      },
      "Funding": {
        "score": 1,
        "evidence": "received no external funding"
      }
    },
    "total_score": 12,
    "max_score": 25
  }
}